Barinthus Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	70.46	110.66	142.09	194.39	214.05
Cash & Short-Term Investments	70.46	110.66	142.09	194.39	214.05
Cash Growth	-36.33%	-22.12%	-26.90%	-9.19%	394.74%
Accounts Receivable	-	-	-	5.85	0.02
Other Receivables	1.31	7.14	7.94	6.31	6.93
Receivables	1.31	7.14	7.94	12.16	6.95
Prepaid Expenses	4.52	5.86	5.4	5.89	4.61
Restricted Cash	1.4	1.74	-	-	-
Other Current Assets	0.12	0.34	1.47	0.61	1.15
Total Current Assets	77.79	125.74	156.91	213.04	226.77
Property, Plant & Equipment	5.16	11.76	19.4	15.71	9.09
Goodwill	-	-	12.21	12.21	12.63
Other Intangible Assets	14.29	21.95	25.11	28.27	31.43
Other Long-Term Assets	0.93	0.88	0.88	0.98	0.8
Total Assets	98.17	160.33	214.51	270.21	280.72
Accounts Payable	0.35	2.47	1.6	3.75	2.42
Accrued Expenses	6.25	9.53	9.21	8.06	7.88
Short-Term Debt	-	-	-	-	0.16
Current Portion of Leases	2.02	1.92	1.79	0.43	0.52
Current Unearned Revenue	1.4	1.74	-	-	0.18
Total Current Liabilities	10.02	15.66	12.6	12.24	11.16
Long-Term Leases	9.26	10.09	11.19	8.34	6.54
Long-Term Deferred Tax Liabilities	0.25	0.44	0.57	3.75	8.08
Other Long-Term Liabilities	4.35	4.01	3.15	2.68	2.37
Total Liabilities	23.88	30.19	27.51	27	28.15
Common Stock	0	0	0	0	0
Additional Paid-In Capital	393.94	393.47	386.6	379.5	369.1
Retained Earnings	-304.09	-237.66	-176.59	-103.24	-108.59
Comprehensive Income & Other	-15.65	-25.78	-23.23	-33.37	-8.39
Total Common Equity	74.21	130.03	186.78	242.9	252.13
Minority Interest	0.08	0.11	0.21	0.31	0.44
Shareholders' Equity	74.29	130.14	187	243.2	252.56
Total Liabilities & Equity	98.17	160.33	214.51	270.21	280.72
Total Debt	11.28	12.01	12.98	8.77	7.22
Net Cash (Debt)	59.18	98.66	129.11	185.61	206.83
Net Cash Growth	-40.02%	-23.59%	-30.44%	-10.26%	-
Net Cash Per Share	1.46	2.51	3.36	4.86	7.99
Filing Date Shares Outstanding	40.85	40.34	38.92	38.34	37.19
Total Common Shares Outstanding	40.85	40.23	38.64	37.68	37.19
Working Capital	67.77	110.09	144.31	200.8	215.61
Book Value Per Share	1.82	3.23	4.83	6.45	6.78
Tangible Book Value	59.92	108.08	149.47	202.42	208.07
Tangible Book Value Per Share	1.47	2.69	3.87	5.37	5.59
Machinery	2.2	7.51	6.84	5.35	2.09
Leasehold Improvements	8.91	9.28	8.67	3.93	0.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.